ArticleScientific reports2021

PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection.

Yoon Jin Cha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.